Two Sigma Advisers
BNR

Two Sigma Advisers’s Burning Rock Biotech BNR Stock Holding History

Two Sigma Advisers’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,400
Closed -$157K – 2558
2022
Q2 		$157K Buy
+5,400
New +$241K ﹤0.01% 2321
2022
Q1 		– Sell
-1,750
Closed -$167K – 2742
2021
Q4 		$167K Buy
+1,750
New +$240K ﹤0.01% 2328

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Two Sigma Advisers's BNR Position: Q3 2022 in Review

Two Sigma Advisers sold out of Burning Rock Biotech (BNR) in Q3 2022, closing a stake of 5,400 shares — an estimated $157K sold.

Two Sigma Advisers first reported a position in BNR in Q4 2021 and held it in 2 quarters. The position peaked at $167K in Q4 2021. 52 funds tracked by Wall St. Rank hold BNR as of Q3 2022.

  • Two Sigma Advisers reported no remaining Burning Rock Biotech position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 5,400 Burning Rock Biotech shares in Q3 2022, an estimated $157K.
  • Two Sigma Advisers first reported a position in Burning Rock Biotech in Q4 2021 and held it in 2 quarters.
  • Two Sigma Advisers's Burning Rock Biotech position peaked at $167K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.